Progranulin as a Potential Therapeutic Target in Immune-Mediated Diseases
Yue-Jiao Lan,1,2 Napoleon Bellua Sam,3 Ming-Han Cheng,1 Hai-Feng Pan,4,5 Jian Gao1 1Pediatric Translational Medicine Institute, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, People’s Republic of China; 2The Second Affiliated Hospital, Dalian Medical...
Guardado en:
Autores principales: | Lan YJ, Sam NB, Cheng MH, Pan HF, Gao J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/94ca2290387d4d6ab0fb7434aed4b006 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Elevated Serum Levels of Progranulin and Soluble Vascular Cell Adhesion Molecule-1 in Patients with COVID-19
por: Yao S, et al.
Publicado: (2021) -
Immune-Mediated Necrotizing Myopathy Initially Presenting as Erythema Nodosum
por: Ying S, et al.
Publicado: (2020) -
The role of TIM-containing molecules in airway disease and their potential as therapeutic targets
por: Vega-Carrascal I, et al.
Publicado: (2012) -
Immune response profiles after caterpillar exposure: a case report
por: Tamar A Smith-Norowitz, et al.
Publicado: (2010) -
Deletion of PPAR-γ in immune cells enhances susceptibility to antiglomerular basement membrane disease
por: Cristen Chafin, et al.
Publicado: (2010)